Citi Pharma Ltd and CCL Pharma (Pvt) Ltd entered into an agreement to manufacture Formulation Products

Citi Pharma Limited and CCL Pharma (Pvt) Limited have executed an agreement to manufacture Formulation Products on their behalf. This will lead to enhanced capacity utilization in the Company;s Formulation segment.

Moreover, this will lead to addition in the Company’s profitability and net margins over the next 2 to 3 years.

spot_img

More like this

MLCF’s subsidiary Novacare to build hospital with $110Mn investment

Novacare Hospitals (Private) Limited, a wholly owned subsidiary of Maple Leaf Cement Factory Limited (PSX: MLCF), will...

SAZEW Three-Wheeler sales declined by 31.6% in Feb

The Sazgar Engineering Works Limited (PSX:SAZEW) announced the production & sales data for the month of February, 2024.Three-Wheelers: The...

MARI has discovered Gas at Maiwand Exploration well in...

MARI Petroleum Company Ltd (PSX: MARI) in a notification to PSX has announced a Gas Discovery at...